NasdaqCM - Nasdaq Real Time Price USD
Elicio Therapeutics, Inc. (ELTX)
5.49
-0.08
(-1.44%)
At close: May 9 at 4:00:00 PM EDT
5.22
-0.27
(-4.92%)
After hours: May 9 at 5:29:05 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 2 |
| Avg. Estimate | -0.83 | -0.66 | -2.4 | -1.94 |
| Low Estimate | -1.15 | -0.71 | -2.58 | -2.59 |
| High Estimate | -0.64 | -0.62 | -2.18 | -1.29 |
| Year Ago EPS | -1.15 | -0.64 | -4.25 | -2.4 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.09 | -0.96 | -0.73 | -0.88 |
| EPS Actual | -1.15 | -0.64 | -1.39 | -1.02 |
| Difference | -0.06 | 0.32 | -0.66 | -0.15 |
| Surprise % | -5.50% | 33.33% | -90.41% | -16.57% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.83 | -0.66 | -2.4 | -1.94 |
| 7 Days Ago | 0 | 0 | -2.94 | -2.4 |
| 30 Days Ago | 0 | 0 | -2.94 | -2.4 |
| 60 Days Ago | -0.82 | -0.76 | -3 | -2.4 |
| 90 Days Ago | -0.82 | -0.76 | -3 | -2.4 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ELTX | 27.83% | -3.65% | 43.53% | 19.17% |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/2/2025 |
| Initiated | Jones Trading: Buy | 10/31/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/23/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/22/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/1/2024 |
Related Tickers
IVA Inventiva S.A.
3.6200
+4.02%
ENTX Entera Bio Ltd.
2.1500
-3.15%
ACTU Actuate Therapeutics, Inc. Common stock
10.35
+4.55%
AARD Aardvark Therapeutics, Inc.
10.42
-2.89%
ERAS Erasca, Inc.
1.3900
0.00%
RLYB Rallybio Corporation
0.2930
0.00%
ENTO Entero Therapeutics, Inc.
0.4190
+5.09%
ELVAF Evolva Holding SA
0.9000
0.00%
EMBT Ember Therapeutics, Inc.
0.0001
0.00%
BETRF BetterLife Pharma Inc.
0.0660
0.00%